1-3 of 3
Luciana Marin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Imatinib-Treated CML Patients With Discordant Response Between Cytogenetic and Molecular Tests At 3 and 6 Month Timepoints Have a Reduced Probability Of Subsequent Optimal Response: A Study From The “Gruppo Triveneto LMC”

Massimiliano Bonifacio, MD, Gianni Binotto, MD, Mario Tiribelli, MD, Elisabetta Calistri, MD, Elena Maino, MD, Roberta Zanotti, MD, Luca Frison, MD, Luciana Marin, MD, Renato Fanin, MD, Gianpietro Semenzato, MD, Giovanni Pizzolo, MD
Journal: Blood
Blood (2013) 122 (21): 2732.
https://doi.org/10.1182/blood.V122.21.2732.2732
Published: 2013
Journal Articles

Clinical Factors Predictive Of Myelofibrotic Evolutions In Patients With Essential Thrombocythemia and Polycythemia Vera

Mario Tiribelli, MD, Federico De Marchi, MD, Daniela Barraco, MD, Luciana Marin, MD, Erika Codarin, PhD, Silvia Buttignol, MD, Daniela Damiani, MD, Renato Fanin, MD
Journal: Blood
Blood (2013) 122 (21): 4082.
https://doi.org/10.1182/blood.V122.21.4082.4082
Published: 2013
Journal Articles

Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.

Mario Tiribelli, MD, Antonio Colatutto, MD, Luciana Marin, MD, Eleonora Toffoletti, MD, Giuseppe Barbina, PhD, Ugo Qualizza, MD, Elio Tonutti, MD, Anna Candoni, MD, Marta Medeot, MD, Daniela Damiani, MD, Giorgio Morocutti, MD, Sala Pierguido, MD, Renato Fanin, MD
Journal: Blood
Blood (2007) 110 (11): 2948.
https://doi.org/10.1182/blood.V110.11.2948.2948
Published: 2007